Balanced news tone
News Sentiment
ACET sentiment intelligence
Adicet Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, +9.7% over four weeks, trend active, and below fair value.
Is Adicet Bio (ACET) stock outpacing its medical peers this year?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
BPAS - Latest News about Adicet Bio, Inc. - Common Stock (Nasdaq:ACET)
This page provides the latest news and press releases concerning Adicet Bio, Inc. (Nasdaq: ACET), detailing various corporate updates, financial results, conference participations, and clinical trial milestones. The stock price for Adicet Bio, Inc. is also displayed, showing a re
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Jun 2026 22:10
- Source
- FinancialContent
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Market source
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Ra Capital buys Adicet Bio (ACET) shares worth $1.6 million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- Investing.com
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Adicet Bio (ACET) Upgraded to Buy: Here's Why
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Oct 2025 07:00
- Source
- Investing.com
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 30 Sep 2025 07:00
- Source
- Market source
Adicet Bio (ACET) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:00
- Source
- Stock Titan